Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (23)

1996

  1. Modulation by nitric oxide of spontaneous motility of the rat isolated duodenum: Role of tachykinins

    British Journal of Pharmacology, Vol. 118, Núm. 6, pp. 1335-1340

1995

  1. Endotoxin inhibition of distension‐stimulated gastric acid secretion in rat: mediation by NO in the central nervous system

    British Journal of Pharmacology, Vol. 114, Núm. 1, pp. 8-12

  2. Nitric oxide and sensory afferent neurones modulate the protective effects of low-dose endotoxin on rat gastric mucosal damage

    European Journal of Pharmacology, Vol. 280, Núm. 3, pp. 339-342

1994

  1. Involvement of endogenous nitric oxide in the inhibition by endotoxin and interleukin‐1β of gastric acid secretion

    Journal of Gastroenterology and Hepatology, Vol. 9, Núm. 1 S, pp. S45-S49

  2. Involvement of neuronal processes and nitric oxide in the inhibition by endotoxin of pentagastrin-stimulated sastric acid secretion

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 349, Núm. 5, pp. 523-527

  3. Nitric oxide donors preferentially inhibit neuronally mediated rat gastric acid secretion

    European Journal of Pharmacology, Vol. 262, Núm. 1-2, pp. 181-183

1993

  1. Nitric oxide mediates the inhibition by interleukin‐1β of pentagastrin‐stimulated rat gastric acid secretion

    British Journal of Pharmacology, Vol. 108, Núm. 1, pp. 9-10

1992

  1. Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion

    Gastroenterology, Vol. 102, Núm. 1, pp. 168-174

  2. Modulation by opioids and by afferent sensory neurones of prostanoid protection of the rat gastric mucosa

    British Journal of Pharmacology, Vol. 106, Núm. 4, pp. 846-852

  3. The role of nitric oxide and platelet-activating factor in the inhibition by endotoxin of pentagastrin-stimulated gastric acid secretion

    European Journal of Pharmacology, Vol. 218, Núm. 2-3, pp. 351-354

1991

  1. Opioid-sensitive peripheral neuronal activity in the modulation of gastric mucosal injury

    Advances in Experimental Medicine and Biology

  2. Vascular interactions between endogenous prostanoids and vasoactive peptide mediators in gastric damage.

    Advances in prostaglandin, thromboxane, and leukotriene research, Vol. 21 B, pp. 761-765

1990

  1. Morphine potentiation of ethanol-induced gastric mucosal damage in the rat. Role of local sensory afferent neurons

    Gastroenterology, Vol. 98, Núm. 1, pp. 82-89

1989

  1. Cardiopulmonary and gastric ulcerogenic actions of endothelin-1 in the guinea pig and ra

    Journal of Cardiovascular Pharmacology, Vol. 13, pp. S103-S107

  2. Direct cytotoxic effect of oxygen radicals on the gastric mucosa

    Surgery, Vol. 106, Núm. 2, pp. 318-324

  3. Gastric damage following local intra-arterial administration of reactive oxygen metabolites in the rat

    British Journal of Pharmacology, Vol. 97, Núm. 4, pp. 1085-1092

  4. Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf

    British Journal of Pharmacology, Vol. 97, Núm. 2, pp. 579-585

  5. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 256, Núm. 2

  6. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation

    European Journal of Pharmacology, Vol. 174, Núm. 2-3, pp. 293-296

1988

  1. Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosa

    Prostaglandins, Vol. 35, Núm. 2, pp. 137-148